Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025 - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)
- [Tech](https://thailandbusinessnews.net/category/tech/)

# Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025

   #####  Up next

  ###### [Ericsson and Google Cloud team up to deliver carrier-grade 5G core as-a-service built with AI at the foundation](https://thailandbusinessnews.net/press-release/ericsson-and-google-cloud-team-up-to-deliver-carrier-grade-5g-core-as-a-service-built-with-ai-at-the-foundation/)

  Published on 12 June 2025 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

 ![](https://mma.prnasia.com/media2/2472549/Fapon_Logo.jpg?p=medium600 "logo")

BOSTON, June 12, 2025 /PRNewswire/ — Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the BIO International Convention 2025 (BIO 2025), taking place June 16-19 in Boston Convention &amp; Exhibition Center. The company will exhibit at Booth #1851, presenting its differentiated pipeline, including the flagship Phase 1 immunocytokine FP008, a portfolio of promising early-stage candidates for oncology and autoimmune diseases, and its suite of proprietary technology platforms, while actively seeking global partnerships.

FP008, Fapon Biopharma’s lead asset, is a first-in-class immunocytokine currently in Phase 1 clinical trials, designed to address significant unmet needs in solid tumor patient refractory to anti-PD-1 therapy. The company will also feature promising preclinical candidates targeting oncology (FP010, FP011, FPE021) and autoimmune diseases (FPE022, FPE024), highlighting its expanding research capabilities.

Fapon Biopharma will feature its proprietary and innovative technology platforms, engineered to overcome complex drug development challenges:

 Bi/Tri-TCE Platform: Human-monkey cross-reactive TCR/CD3 nanobody, enabling the design of potent multi-specific antibodies for targeted cancer immunotherapy. FILTEN™ (IL-10M Fusion Protein Platform): Overcoming IL-10 limitations for broad applications in cancer and autoimmune diseases PROTiNb™ (Proteolysis Targeting Intra-Nanobody): A pioneering platform targeting previously "undruggable" intracellular targets, demonstrating a strong competitive edge. FIND™ Mammalian Cell Display Platform: Accelerating antibody discovery by combining mammalian cell expression with high-throughput screening.

"We are excited to connect with the global biopharma community at BIO 2025," said Vincent Huo, President of Fapon Biopharma. "We look forward to demonstrating the exciting progress of our internal pipeline and how our technology platforms can empower external partners to bring transformative therapy to patients faster."

Engagement Opportunities:Exhibition Booth: #1851Company Presentation: Time: 11:30 a.m., Tuesday, June 17, 2025Location: Room 153A, Boston Convention &amp; Exhibition Center

To schedule a meeting in advance or during the conference, please contact our BD representatives, Max Wang (<max.wang@fapon.com>) and Liyan Gao (<liyan.gao@fapon.com>), or visit us at Booth #1851. Meetings can also be requested via the BIO partnering system.

About Fapon Biopharma (<https://en.faponbiopharma.com/>)

Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologies, we have built advanced drug discovery platforms, including an antibody discovery platform based on the globally leading mammalian cell display technology, a platform for generating IL-10M fusion proteins, and a platform for developing multispecific antibodies using Fibody and nanobodies. With a differentiated pipeline of leading drug candidates, we have established capabilities that cover the entire drug development process from drug discovery, preclinical research, Chemistry, Manufacturing and Controls (CMC) to early clinical development. Committed to innovation, we strive to deliver safer, more efficacious, affordable, and accessible biologics for everyone.

[Source link ](https://www.prnasia.com/story/archive/4709090_CN09090_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/hnse-asia-ai-hardware-battle-2025-adds-japan-retail-showcase-for-top-10-winners-application-deadline-extended-to-july-12/) ![HNSE Asia AI Hardware Battle 2025 Adds Japan Retail Showcase for Top 10 Winners; Application Deadline Extended to July 12](https://i0.wp.com/r2.thailandbusinessnews.net/2025/07/image_800964_11987409.jpg?resize=260%2C140&ssl=1 "HNSE Asia AI Hardware Battle 2025 Adds Japan Retail Showcase for Top 10 Winners; Application Deadline Extended to July 12")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## HNSE Asia AI Hardware Battle 2025 Adds Japan Retail Showcase for Top 10 Winners; Application Deadline Extended to July 12

  LINGSHUI, China, July 3, 2025 /PRNewswire/ — The organizers of the HaiNan-Southeast Asia…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- July 3, 2025

   [](https://thailandbusinessnews.net/press-release/ibm-expands-granite-model-family-with-new-multi-modal-and-reasoning-ai-built-for-the-enterprise/) ![IBM Expands Granite Model Family with New Multi-Modal and Reasoning AI Built for the Enterprise](https://i0.wp.com/r2.thailandbusinessnews.net/2025/02/IBM_Granite.jpg?resize=260%2C140&ssl=1 "IBM Expands Granite Model Family with New Multi-Modal and Reasoning AI Built for the Enterprise")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## IBM Expands Granite Model Family with New Multi-Modal and Reasoning AI Built for the Enterprise

  Granite 3.2 – small AI models offering reasoning, vision, and guardrail capabilities…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- February 26, 2025

   [](https://thailandbusinessnews.net/press-release/veout-unveils-exciting-deals-on-acclaimed-portable-monitors-the-top-choice-for-young-consumers/) ![Veout Unveils Exciting Deals on Acclaimed Portable Monitors, the Top Choice for Young Consumers](https://i0.wp.com/r2.thailandbusinessnews.net/2024/11/WechatIMG204.jpg?resize=260%2C140&ssl=1 "Veout Unveils Exciting Deals on Acclaimed Portable Monitors, the Top Choice for Young Consumers")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## Veout Unveils Exciting Deals on Acclaimed Portable Monitors, the Top Choice for Young Consumers

  NEW YORK, Nov. 29, 2024 /PRNewswire/ — Veout, a brand dedicated to…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- November 28, 2024

 ##### Most Read

- [![Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme") [Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme](https://thailandbusinessnews.net/press-release/priority-pass-to-accelerate-travel-innovation-backed-by-the-collinson-groups-500-million-growth-programme-2/ "Priority Pass to accelerate travel innovation, backed by the Collinson Group's £500 million growth programme")
- [![IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution") [IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution](https://thailandbusinessnews.net/press-release/img-completes-acquisition-of-world-nomads-expanding-global-travel-insurance-distribution/ "IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution")
- [![Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://i0.wp.com/r2.thailandbusinessnews.net/2025/04/MODERN_MEADOW_LOGO_BLACK_PNG_Logo.jpg?fit=597%2C138&ssl=1&resize=40%2C40)](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material") [Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material](https://thailandbusinessnews.net/press-release/modern-meadow-and-bellroy-partner-on-carry-products-made-of-next-generation-material/ "Modern Meadow and Bellroy Partner on Carry Products Made of Next-Generation Material")
- [![DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity") [DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity](https://thailandbusinessnews.net/press-release/dorco-wins-2026-red-dot-award-for-renewed-corporate-identity/ "DORCO Wins 2026 Red Dot Award for Renewed Corporate Identity")
- [![Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access") [Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access](https://thailandbusinessnews.net/press-release/tamarind-health-launches-rare-cancer-centre-to-make-specialist-expertise-easier-to-access/ "Tamarind Health launches Rare Cancer Centre to make specialist expertise easier to access")
- [![MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access") [MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access](https://thailandbusinessnews.net/press-release/memomind-one-rolls-out-new-features-and-prepares-for-a-new-stage-of-developer-access/ "MemoMind One Rolls Out New Features and Prepares for a New Stage of Developer Access")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/midea-and-electrolux-group-officially-begin-new-chapter-in-north-america-as-all-three-joint-ventures-go-live/) ![Midea and Electrolux Group Officially Begin New Chapter in North America as All Three Joint Ventures Go Live](https://i0.wp.com/mmx.prnasia.com/media/MS2001111/20261001142300EDT_image_1.jpg?resize=260%2C140&ssl=1 "Midea and Electrolux Group Officially Begin New Chapter in North America as All Three Joint Ventures Go Live")

 ## Midea and Electrolux Group Officially Begin New Chapter in North America as All Three Joint Ventures Go Live

  By combining their complementary strengths, the two companies are creating a more…

   [](https://thailandbusinessnews.net/press-release/sekisui-specialty-chemicals-announces-global-price-increase-4/) ## Sekisui Specialty Chemicals Announces Global Price Increase

  DALLAS, Oct. 2, 2026 /PRNewswire/ — Sekisui Specialty Chemicals announced today…

   [](https://thailandbusinessnews.net/press-release/i-peace-selected-as-a-top-10-awardee-for-the-top-10-longevity-breakthrough-awards-2026/) ## I Peace Selected as a TOP 10 Awardee for the "Top 10 Longevity Breakthrough Awards 2026"

  PALO ALTO, Calif., Oct. 2, 2026 /PRNewswire/ — I Peace Inc., a…

   [](https://thailandbusinessnews.net/press-release/ena-members-choose-vanessa-gorman-as-2027-president-elect/) ![ENA Members Choose Vanessa Gorman as 2027 President-elect](https://i0.wp.com/mmx.prnasia.com/media/MS2001189/Vanessa-Gorman-800.jpg?resize=260%2C140&ssl=1 "ENA Members Choose Vanessa Gorman as 2027 President-elect")

 ## ENA Members Choose Vanessa Gorman as 2027 President-elect

  Secretary/treasurer, two board members also picked in annual election SCHAUMBURG, Ill.,…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
